5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 146.06▲ | 146.23▼ | 146.11▲ | 144.97▲ | 143.58▲ |
MA10 | 146.10▲ | 146.06▲ | 145.72▲ | 144.94▲ | 138.04▲ |
MA20 | 146.18▲ | 145.60▲ | 145.07▲ | 142.57▲ | 132.91▲ |
MA50 | 146.09▲ | 145.03▲ | 144.76▲ | 136.48▲ | 125.03▲ |
MA100 | 145.69▲ | 144.77▲ | 144.86▲ | 131.13▲ | 114.06▲ |
MA200 | 145.07▲ | 144.28▲ | 140.15▲ | 124.82▲ | 106.29▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.021▼ | 0.036▲ | 0.141▲ | -0.160▼ | 1.360▲ |
RSI | 53.572▲ | 70.129▲ | 67.867▲ | 69.980▲ | 75.435▲ |
STOCH | 34.893 | 83.601▲ | 88.015▲ | 49.197 | 89.498▲ |
WILL %R | -34.667 | -18.881▲ | -11.227▲ | -25.827 | -7.402▲ |
CCI | 5.151 | 54.305 | 86.006 | 140.006▲ | 124.474▲ |
Tuesday, September 16, 2025 08:53 AM
RBC Capital Markets launched its coverage of Kymera Therapeutics (NASDAQ:KYMR) with an Outperform rating on Tuesday, citing the potential of its lead drug KT-621, targeted at inflammatory conditions ...
|
Monday, September 15, 2025 03:20 PM
Royal Bank of Canada (TSX: RY) and (NYSE: RY) today announced the offering of US$1.35 billion of non-viability contingent capital (“NVCC”) Additional Tier 1 ...
|
Sunday, September 14, 2025 12:35 AM
Detailed price information for Royal Bank of Canada (RY-T) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 145.40 | 146.50 | 145.18 | 146.04 | 797,810 |
15/09/25 | 144.51 | 145.42 | 144.04 | 145.39 | 798,620 |
12/09/25 | 144.88 | 144.95 | 143.995 | 144.14 | 549,830 |
11/09/25 | 144.55 | 145.21 | 144.39 | 145.13 | 635,686 |
10/09/25 | 144.07 | 144.68 | 143.97 | 144.14 | 765,600 |
09/09/25 | 144.33 | 144.96 | 143.941 | 143.99 | 741,974 |
08/09/25 | 145.05 | 145.22 | 144.171 | 144.61 | 457,853 |
05/09/25 | 145.93 | 146.50 | 143.97 | 144.49 | 975,000 |
04/09/25 | 146.03 | 146.30 | 145.19 | 145.81 | 553,500 |
03/09/25 | 145.00 | 145.64 | 144.72 | 145.64 | 653,583 |
|
|
||||
|
|
||||
|
|